Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Cancer, Combined Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06704724
What this trial is testing

Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 30
Early research (Phase 1)Ended earlyNCT06052852
What this trial is testing

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more
Bolt Biotherapeutics, Inc. 17
Early research (Phase 1)UnknownNCT05259319
What this trial is testing

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)

Who this might be right for
Metastatic Non Small Cell Lung CancerMetastatic Bladder CancerMetastatic Renal Cell Carcinoma+1 more
Centre Georges Francois Leclerc 92
Not applicableNot Yet RecruitingNCT07538193
What this trial is testing

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung (NSCLC)Neoplasm StagingLymphatic Metastasis
Tang-Du Hospital 28
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04165330
What this trial is testing

Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors

Who this might be right for
Solid Tumor, AdultSoft Tissue SarcomaNon Small Cell Lung Cancer+1 more
Sarcoma Oncology Research Center, LLC 56
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Testing effectiveness (Phase 2)Study completedNCT00001499
What this trial is testing

Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungLung Neoplasms
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01451632
What this trial is testing

A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

Who this might be right for
Colorectal CancerSquamous Cell Head and Neck CancerNon-small Cell Lung Cancer+2 more
Merrimack Pharmaceuticals 48
Early research (Phase 1)Looking for participantsNCT05403554
What this trial is testing

NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Who this might be right for
Epithelial Ovarian CancerTriple Negative Breast CancerNon-squamous Non-small-cell Lung Cancer+2 more
Light Chain Bioscience - Novimmune SA 70
Testing effectiveness (Phase 2)Study completedNCT03647488
What this trial is testing

Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 18
Large-scale testing (Phase 3)UnknownNCT03952403
What this trial is testing

HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung
Shanghai Henlius Biotech 643
Not applicableActive Not RecruitingNCT01345851
What this trial is testing

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+6 more
Jonsson Comprehensive Cancer Center 29
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Post-approval studies (Phase 4)UnknownNCT04401059
What this trial is testing

Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study

Who this might be right for
CarcinomaNon-Small-Cell Lung CancerAdenocarcinoma
Tian Xie 744
Testing effectiveness (Phase 2)Study completedNCT01039948
What this trial is testing

A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell-LungLung NeoplasmsLung Cancer+1 more
AVEO Pharmaceuticals, Inc. 203
Post-approval studies (Phase 4)Study completedNCT02151149
What this trial is testing

Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Who this might be right for
Non-Small Cell Lung CancerCarcinomaSquamous Cell Carcinoma+3 more
Celgene 143
Testing effectiveness (Phase 2)Active Not RecruitingNCT05887492
What this trial is testing

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Who this might be right for
Non Small Cell Lung CancerSolid Tumors, AdultLung Cancer+1 more
Tango Therapeutics, Inc. 126
Testing effectiveness (Phase 2)Study completedNCT00081302
What this trial is testing

Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group
Next Page